Starmap Medicine & Technology Co Ltd operates within the Food crops grown under cover sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Starmap Medicine & Technology Co Ltd with three other
fruit and vegetable producers in Asia:
China Greenfresh Group Co Ltd
of Hong Kong
sales of 1.23 billion Hong Kong Dollars [US$156.92 million]
of which 39%
Tianshui Zhongxing Bio-technology Co Ltd
(739.79 million Chinese Renmimbi [US$106.58 million]
of which 100%
was Planting), and
Shanghai Xuerong Biotechnology Co Ltd
(1.33 billion Chinese Renmimbi [US$191.65 million]
of which 99%
was Edible fungi industry).
During the year ended December of 2017, sales at
Starmap Medicine & Technology Co Ltd were 329.23 million Chinese Renmimbi (US$47.43 million).
decrease of 23.9%
versus 2016, when the company's sales were 432.45 million Chinese Renmimbi.